NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

NCT07048197

RecruitingPhase 1, Phase 2

Sponsor: Novartis Pharmaceuticals

Conditions: Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)

Interventions: Rapcabtagene autoleucel

Countries: France, Germany, Singapore, Spain

A study to assess safety, cellular kinetics and exploratory efficacy of rapcabtagene autoleucel in rheumatoid arthritis and Sjogren's disease

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Signed informed consent must be obtained prior to participation in the study
* Men and women aged ≥ 18 years and ≤ 75 years at Screening For RA only
* Diagnosis of rheumatoid arthritis
* Treatment failure of standard of care therapies
* Active disease For SjD only
* Diagnosis of Sjogren's disease
* Active disease

Exclusion Criteria:

* BMI at Screening of ≤17 or ≥ 40 kg/m2
* Clinically significant active, opportunistic, chronic or recurrent infection
* Sexually active males unwilling to use a condom during intercourse from the time enrollment
* Women of childbearing potential, unless they are using a highly effective method of contraception starting from the time of enrollment
* Female participants who are pregnant, breastfeeding or intending to conceive during the course of the study
* Inadequate organ function during screening
* History of lymphoproliferative disease or any known malignancy or history of malignancy
* History of bone marrow/hematopoietic stem cell or solid organ transplantation
* Any psychiatric condition or disability making compliance with treatment or informed consent impossible

Other protocol-defined inclusion/exclusion criteria may apply.
Locations (12)
  • Bordeaux, France
  • Brest, France
  • Le Kremlin-Bicêtre, France
  • Lille, France
  • Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Göttingen, Lower Saxony, Germany
  • Cologne, North Rhine-Westphalia, Germany
  • Berlin, Germany
  • Ulm, Germany
  • Singapore, Singapore
  • Barcelona, Spain
  • Madrid, Spain